87
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Cost effectiveness and cost utility of the noncoding blood glucose meter CONTOUR® TS

&
Pages 79-88 | Published online: 10 Feb 2011

References

  • Vinik AI Vinik E Prevention of the complications of diabetes Am J Manag Care 2003 9 3 Suppl S63 S80 12653455
  • International Diabetes Federation Diabetes Atlas Diabetes [homepage on the Internet]. Available from: http://www.diabetesatlas.org/content/diabetes. Accessed November 23, 2010.
  • Bragd J Adamson U Backlund LB Lins PE Moberg E Oskarsson P Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab 2008 34 6 612 616 18824382
  • The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 1993 329 14 977 986 8366922
  • Kruger DF Martin CL Sadler CE New insights into glucose regulation Diabetes Educ 2006 32 2 221 228 16554425
  • Steffes MW Glycemic control and the initiation and progression of the complications of diabetes mellitus Kidney Int Suppl 1997 63 S36 S39 9407418
  • Menzin J Langley-Hawthorne C Friedman M Boulanger L Cavanaugh R Potential short-term economic benefits of improved glycemic control: a managed care perspective Diabetes Care 2001 24 1 51 55 11194241
  • Wagner EH Sandhu N Newton KM McCulloch DK Ramsey SD Grothaus LC Effect of improved glycemic control on health care costs and utilization JAMA 2001 285 2 182 189 11176811
  • Raine CH Schrock LE Edelman SV Significant insulin dose errors may occur if blood glucose results are obtained from miscoded meters J Diabetes Sci Technol 2007 1 2 205 210 19888408
  • Kristensen GB Nerhus K Thue G Sandberg S Standardized evaluation of instruments for self-monitoring of blood glucose by patients and a technologist Clin Chem 2004 50 6 1068 1071 15161725
  • Frank J Rivera L Wallace JF Parkes JL Performance and Ease of Use of the CONTOURTM™ TS Blood Glucose Monitoring System: Capillary, Venous and Alternative Site Testing (AST) Blood Tarrytown, NY Bayer HealthCare Diabetes Care 2007
  • Tufts Medical Center, Institute for Clinical Research and Health Policy Studies The Cost Effectiveness Analysis Registry Database, Center for the Evaluation of Value and Risk in Health (CEVR) [homepage on the Internet] Available from: https://research.tufts-nemc.org/cear/. Accessed December 3, 2008.
  • Ministerstwo Zdrowia Internet portal of the Ministry of Health [homepage on the Internet] Available from: http://www.mz.gov.pl/. Accessed November 11, 2008.
  • Medycyna Praktyczna Portal [homepage on the Internet] Available from: http://www.mp.pl. Accessed November 11, 2008.
  • Health Technology Assessment Agency website [homepage on the Internet] Available from: http://www.aotm.gov.pl/. Accessed November 11, 2008.
  • Central Statistical Office of Poland National Census of People and Dwellings 2011 [homepage on the Internet] Available from: http://www.stat.gov.pl./gus/index_ENG_HTML.htm. Accessed November 23, 2010.
  • Goldstein DE Little RR Lorenz RA Tests of glycemia in diabetes Diabetes Care 2004 27 7 1761 1773 15220264
  • Farmer A Wade A Goyder E Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial BMJ 2007 335 7611 132 17591623
  • Palmer AJ Roze S Valentine WJ The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making Curr Med Res Opin 2004 20 Suppl 1 S5 S26 15324513
  • Stratton IM Adler AI Neil HAW Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 2000 321 7258 405 412 10938048
  • Molyneaux LM Constantino MI McGill M Zilkens R Yue DK Better glycaemic control and risk reduction of diabetic complications in Type 2 diabetes: comparison with the DCCT Diabetes Res Clin Pract 1998 42 2 77 83 9886743
  • Kumala-Szczeklik Z Tatón J Wplyw cukrzycy na wsakaŸniki chorobowoœci I œmiertelnoœcu w powodu ostrego zawalu serca Medycyna Metaboliczna 1999 92 169 173
  • Wiener K Roberts NB Age does not influence levels of HbA1c in normal subject QJM 1999 92 3 169 173 10326076